Actively Recruiting
Study of Lichen Sclerosus in Men Risk Factors, Treatment, and Effects on Quality of Life with Long-Term Follow-Up
Led by Region Västerbotten · Updated on 2026-02-10
300
Participants Needed
1
Research Sites
521 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying men with lichen sclerosus LS, a chronic inflammatory skin condition affecting the genital area, to understand treatment outcomes, disease progression, and effects on quality of life and sexual health. This observational study focuses on men diagnosed with LS, investigating risk factors and histopathological changes over time. The study also aims to assess long-term impacts, including the development of epithelial atypia. Participants include men undergoing circumcision for phimosis caused by LS and men diagnosed with LS treated in outpatient dermatology care. Some participants will provide biological samples such as skin, urine, and feces for exploratory analysis of microbiome and metabolic profiles. The study also includes control groups of men without LS, some undergoing circumcision for phimosis unrelated to LS, and healthy men without genital symptoms. Men in the study will complete questionnaires about symptoms, quality of life, and sexual health. Follow-up assessments occur at multiple time points up to 10 years to monitor clinical outcomes and changes. Researchers will evaluate treatment effects, quality of life using the Dermatology Life Quality Index, and detect any tissue changes. Biological samples collected at baseline support further research on LS. Participation includes long-term monitoring and questionnaires, with no interventions assigned by the study.
CONDITIONS
Brief Title
Male Lichen Sclerosus - Risk Factors, Treatment, and Impact on Quality of Life
Research Team
M
Maja af Klinteberg, MD, PhD
A
Amir Sherif, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here